Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PRASUGREL HYDROCHLORIDE, with a corresponding US DMF Number 25898.
Remarkably, this DMF maintains an Active status since its submission on March 21, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 12, 2013, and payment made on May 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II